Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 28;12(3):1003.
doi: 10.3390/jcm12031003.

Analysis of Salivary Levels of IL-1β, IL17A, OPG and RANK-L in Periodontitis Using the 2017 Classification of Periodontal Diseases-An Exploratory Observational Study

Affiliations

Analysis of Salivary Levels of IL-1β, IL17A, OPG and RANK-L in Periodontitis Using the 2017 Classification of Periodontal Diseases-An Exploratory Observational Study

Marta Relvas et al. J Clin Med. .

Abstract

Periodontitis is a chronic disease with a high overall prevalence. It involves a complex interplay between the immune-inflammatory pathways and biofilm changes, leading to periodontal attachment loss. The aims of this study were (i) to assess whether the salivary IL-1β, IL-17A, RANK-L and OPG levels have the potential to discriminate between the mild and severe periodontitis conditions; and (ii) to enable diagnostic/prognostic actions to differentiate between distinct levels of the disease. The analysis of the clinical parameters and the evaluation of the salivary immunomediators levels by means of a multiplex flow assay revealed a statistically significantly higher level of IL-1β in the periodontitis III/IV patients, as well as a higher level of RANK-L in the periodontitis III/IV and I/II patients, when compared to the healthy controls. Furthermore, the grade C periodontitis patients presented a significantly higher level of RANK-L compared to the grade B and grade A patients. In the grade C patients, IL-1β had a positive correlation with the PPD and CAL indices and RANK_L had a positive correlation with CAL. The evidence emerging from this study associates the salivary IL-1β and RANK-L levels with an advanced stage of periodontitis, stage III/IV, and with grade C, suggesting the possible cooperative action of both in the inflammatory and bone loss events. In addition to IL-1β, RANK-L could be considered a combined diagnostic biomarker for periodontitis.

Keywords: IL-1β; IL17-A; OPG; RANK-L; biomarkers; grade; periodontitis; saliva; stage.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Scatter plots of IL-1β, OPG, IL17-A and RANK-L salivary levels (pg/mL) in the different grade groups. OPG: osteoprotegerin: IL-1β: interleukin -1β; RANK-L: receptor activator of nuclear factor kappa-B ligand; IL-17A: inteleukin- 17A; RANK-L/OPG: RANKL/OPG ratio; Horizontal lines represent M(SD) = mean (standard deviation). Statistical analysis with p value derived from the ANOVA one-way test and Bonferroni test (p = 0.035).

Similar articles

Cited by

References

    1. Dentino A., Lee S., Mailhot J., Hefti A.F. Principles of periodontology. Periodontology 2000. 2013;61:16–53. doi: 10.1111/j.1600-0757.2011.00397.x. - DOI - PubMed
    1. Kassebaum N.J., Bernabé E., Dahiya M., Bhandari B., Murray C.J.L., Marcenes W. Global burden of severe periodontitis in 1990–2010: A systematic review and meta-regression. J. Dent. Res. 2014;93:1045–1053. doi: 10.1177/0022034514552491. - DOI - PMC - PubMed
    1. Hajishengallis G., Korostoff J.M. Revisiting the Page & Schroeder model: The good, the bad and the unknowns in the periodontal host response 40 years later. Periodontology 2000. 2017;75:116–151. - PMC - PubMed
    1. Van Dyke T.E. Inflammation and periodontal diseases: A reappraisal. J. Periodontol. 2008;79:1501–1502. doi: 10.1902/jop.2008.080279. - DOI - PubMed
    1. Goodson J.M., Haffajee A.D., Socransky S.S., Kent R., Teles R., Hasturk H., Bogren A., Van Dyke T., Wennstrom J., Lindhe J. Control of periodontal infections: A randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. J. Clin. Periodontol. 2012;39:526–536. - PubMed

LinkOut - more resources